Teclistamab,Daratumumab,Pomalidomide,Lenalidomide,Bortezomib,Nirogacestat
Genmab,Janssen,springworks therapeutics,Takeda,bms
[]
 this was my concern too, esp since risk for infection would be driving factor to reservering for later lines. i think adding tec to len increases severe neutropenia; would be interested to see if this could be mitigated with gcsf &amp; antimicrobials #ash22
Current Hem-Onc Fellow at Emory. Former Resident @ClevelandClinic and Former @WayneMedicine & @UMich graduate. Coffee is my daily vice. Tweets are my own